ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
ResMed (NYSE: RMD) announced that Rob Douglas, the president and COO, will present at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at approximately 11:20 a.m. EDT. The presentation will be accessible via a webcast, and interested parties can find more information and access the live stream on ResMed's investor relations website. A replay will be available approximately 24 hours after the event and can be accessed for 90 days. ResMed specializes in innovative solutions for chronic diseases, enhancing care with digital health technologies and cloud-connected medical devices across over 140 countries.
- Rob Douglas, president and COO, presenting at a notable healthcare conference, which could enhance company visibility and investor interest.
- Innovative solutions targeting chronic diseases, potentially improving demand and revenue.
- None.
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, beginning at approximately 11:20 a.m. (Eastern Daylight Time) via webcast.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com | For media Jayme Rubenstein +1 858.836.6798 news@resmed.com |
FAQ
When will Rob Douglas present at the Oppenheimer 33rd Annual Healthcare Conference?
How can I access the webcast of ResMed's conference presentation?
What is ResMed's focus in healthcare?
What is the ticker symbol for ResMed?
